Clinical Trial: Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase II Treatment of Adults With Newly Diagnosed, Progressive or Recurrent Primary Malignant Anaplastic Oligodendroglioma With Temodal

Brief Summary:

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients with anaplastic oligodendroglioma.